Aspire Biopharma Holdings Overview
Aspire Biopharma Holdings Discounted Cash Flow
DCF Analysis for ASBP.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.25
Current Fair Value
$-0.25
↓ 105.1% Downside
Overvalued by 105.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison